Tuesday, October 27, 2020
wellness India Expo
Home Tags Biopharma

Tag: biopharma

16th edition of BioAsia 2019 kicks off at Hyderabad

On the first day, the Genome Valley Excellence Award 2019 was presented to Dr Don W. Cleveland of the University of California recognizing his pioneering work in cancer genetics. Also, the Governor of Telangana launched State government’s Vaccine Skilling program...………….

4677 generic medicine centres made functional by the end of 2018

As per the union government, unbranded generic medicines worth Rs 417 crores (MRP) have been sold through 4677 ‘Pradhan Mantri Bhartiya Jan Aushadhi Pariyojana’ (PMBJP) Kendras that are functional in 35 States/UTs of the country...………..

India seeks greater market access for agri & pharma products in...

The top commerce ministry officials of India and China discussed the various issues related to commercial transactions between two nations including widening trade deficit...……….

US-China trade war offers window of opportunity for Indian pharma sector

As per the leading data and analytics company GlobalData, the standoff between China and India over regulatory issues provides great opportunity for the Indian pharma firms to penetrate the Chinese healthcare market and reduce trade deficit...………..

Telangana govt proposes a mega biopharma hub at Genome Valley

The proposed facility, to come up with an estimated cost of Rs 60 crore, will be set up through Public Private Partnership in Genome Valley, which is India's first organised cluster for life sciences R&D and clean manufacturing activities.

#HealthMeetsHope: OPPI launches digital campain for fresh ideas at its annual...

OPPI has launched the #ThinkForHealth, a nation-wide digital campaign in partnership with the Government of Telangana. Winning ideas which contribute to building a healthier future will be heard, rewarded and mentored...……….

Holistic approach may bring true innovation to pharma world, says GlobalData

Major pharma companies are facing massive challenges in developing truly innovative drugs and to minimize risk in internal R&D, they have been mainly relying on outside innovation by biotech firms.................

India has immense potential in biomedical science to improve healthcare: Report

The latest report titled 'Unlocking India's Potential in Biomedical Science & Innovation to improve healthcare in India and for the World' provides recommendations from the insights shared by the key experts around bolstering the growth of biomedical and biopharma.................

US FDA approves Mylan & Biocon’s biosimilar, Fulphila

Second FDA-approved biosimilar through the Mylan-Biocon collaboration,, Fulphila is expected to be the first biosimilar pegfilgrastim available in the U.S. to help patients with nonmyeloid cancers reduce the risk of infection...............

Merck to transfer certain businesses to Merck Life Science for 1,052...

The transfer of assets, however, is subject to the approval of the shareholders of the company and other statutory nods..............